SCHEDULE: FMR LLC Maintains 9.1% Stake in Astria Therapeutics
Beneficial Ownership Report (Amendment)
FMR LLC and Abigail P. Johnson have filed an amended Schedule 13G, disclosing a continued 9.1% beneficial ownership in Astria Therapeutics Inc. common stock.
Summary
- FMR LLC and Abigail P. Johnson reported beneficial ownership of 5,153,914.05 shares of Astria Therapeutics Inc. common stock.
- This represents 9.1% of the total outstanding common stock of Astria Therapeutics Inc.
- FMR LLC holds sole voting power over 5,151,876.00 shares and sole dispositive power over 5,153,914.05 shares.
- Abigail P. Johnson, as a control person of FMR LLC, is deemed to beneficially own the same aggregate amount of shares with sole dispositive power.
- The filing is an Amendment No. 7 to a Schedule 13G, indicating a previous filing and an update to the ownership stake.
- The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.
Sentiment
Score: 6
Explanation: The sentiment is moderately positive due to the continued significant institutional ownership by FMR LLC, which can be interpreted as a vote of confidence, although the filing itself is a factual disclosure without operational details.
Positives
- The continued significant stake (9.1%) by a major institutional investor like FMR LLC may signal ongoing confidence in Astria Therapeutics Inc.
Negatives
- NA
Risks
- This filing does not contain specific risk factors related to Astria Therapeutics Inc. operations or financial health, as it is an ownership disclosure.
Future Outlook
This filing does not provide any forward-looking statements or guidance regarding Astria Therapeutics Inc.'s future performance or strategic direction.
Management Comments
- NA
Industry Context
This filing is a routine disclosure of institutional ownership and does not provide specific analysis of Astria Therapeutics Inc.'s position within the broader biotechnology or pharmaceutical industry trends.
Comparison to Industry Standards
- NA
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| NA | NA | NA | NA | This filing does not report any management changes for Astria Therapeutics Inc. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| NA | This filing does not report any changes in corporate governance for Astria Therapeutics Inc. | NA | NA |
Legal Proceedings
- NA
Related Party Transactions
- NA
Stakeholder Impact
- Shareholders: The continued significant ownership by a prominent institutional investor like FMR LLC may enhance investor confidence and perception of the company's stability and potential.
Next Steps
- NA
Key Dates
| Date | Description |
|---|---|
| 2025-09-30 | Date of event which requires filing of this statement |
| 2025-11-04 | Signature date for FMR LLC and Abigail P. Johnson |
Keywords
Astria Therapeutics, FMR LLC, Abigail P. Johnson, Schedule 13G, Beneficial Ownership, Institutional Investor, Common Stock, Biotechnology, Pharmaceuticals
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.